Multiple Myeloma

Multiple Myeloma News

  • U.S. Court Upholds Takeda Patent on Cancer Drug Velcade A U.S. appeals court ruled on Monday that a patent on Takeda Pharmaceutical Co Ltd's cancer treatment Velcade (bortezomib) is valid, pushing back the date when generic drug makers including Teva Pharmaceutical Industries Ltd and Mylan NV will be allowed to launch lower-cost versions of the drug in the United States.
  • 'Incredibly Exciting': CAR T Cells as 'Living Drugs' Unlike drugs that gradually disappear from the body, CAR T cells are 'living drugs' that persist in the body for years.
 

Multiple Myeloma Perspective

 

Journals